DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Ryan W. Stidham, MD, MSc
Siddharth Singh, MD
Panel Discussion - Cohen, Matro, Worsey
Benjamin L. Cohen, MD
Rebecca Matro, MD
Jonathan Worsey, MD, FACS, FRCS
APP IBD Preceptorship Faculty Directors Testimonials
Mary Kate Preite, NP
Maureen Kelly, MS, RN, CPNP
Michele Rubin, BSN, MSN, APRN-CNS, CGRN
Susie K. Lee, NP
IBD Qorus
Gil Melmed, MD, MS
Corey A. Siegel, MD, MS
Alandra Weaver, MPH
Building Blocks to Better IBD Veteran Patient Care: The APP Perspective
Sylvia Ehle, MHA
Elena Fisher, DNP, FNP-C
Victoria Barden, PA-C
APP Biosimilar Education Video Series Module 3
Jamie T. Brogan, APRN
Angelina Collins, MSN, ANP-BC
APP Biosimilar Education Video Series Module 1
Donna Bacchus, PhD, MSN, RN
Juanita Belton, MPH, PA-C
APP Biosimilar Education Video Series Module 2
Isabel Roitman, MBA, NP-BC
Whitney Gray, CRNP
APP Biosimilar Education Video Series Module 4
Ross M. Maltz, MD
Short Bowel Syndrome
Kendall Beck, MD
State of the Art Management of IBD: How Should We Sequence Therapies and Monitor the Disease?
David T. Rubin, MD
Biologics and Biosimilars
Bincy P. Abraham, MD, MS
Practical Pearls and Navigating Barriers to Advanced IBD Therapeutics
Anh-Thu Truong, PharmD
Novel Small Molecule Therapy
Ronald Hsu, M.D., FACG, FACP
Inequities in IBD Care
Jesse Lee Stondell, M.D.
Integrating Psychogastroenterology into Clinical Practice
Alyse Bedell, PhD
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.